COLD GENESYS INC has a total of 19 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are GENPHAR INC, TAKEDA VACCINES INC and NABEL GARY J.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 2 | |
#6 | Republic of Korea | 1 | |
#7 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Kuan Arthur | 14 |
#2 | Yeung Alex Wah Hin | 9 |
#3 | Henderson Daniel R | 3 |
#4 | Yu De-Chao | 2 |
#5 | Little Andrew S | 1 |
#6 | Li Yuanhao | 1 |
#7 | Yu Dechao | 1 |
#8 | Ramesh Nagarajan | 1 |
#9 | Memarzadeh Bahram | 1 |
#10 | Frey David | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018191654A1 | Methods of treating bladder cancer | |
EP3426271A1 | Methods of treating solid or lymphatic tumors by combination therapy | |
US2018318365A1 | Methods of treating solid or lymphatic tumors by combination therapy |